Midgard Science

Labs / Assays & in vitro testing

Allterum Therapeutics

Houston, TX, United States · allterum.com

GMP

Allterum Therapeutics develops precision oncology and inflammation therapies. Its lead program is 4A10, a monoclonal antibody targeting CD127, with work focused on relapsed leukemia, hematologic malignancies, and CD127-expressing solid tumors. The company is based in Houston and collaborates with cancer researchers and institutions in Texas and elsewhere in the U.S.

They take quote requests by email.

What they offer

  • Therapeutic antibody development

    Develops monoclonal antibody therapeutics directed at specific disease targets, including CD127.

  • Precision oncology drug development

    Advances oncology programs focused on targeted therapies for hematologic malignancies and solid tumors.

  • Inflammation therapeutics development

    Develops therapies for inflammation-related indications as part of its precision medicine focus.

  • Translational science collaboration

    Works with academic and clinical partners to advance therapeutic programs from discovery toward the clinic.

What they work on

Modalities
Small molecule, Antibody
Therapeutic areas
precision oncology, inflammation, relapsed leukemia, acute lymphoblastic leukemia (ALL), B-cell malignancies, lymphomas, solid tumors, hematologic malignancies
Sites
Houston, USA
Address
10401 Town Park Drive, Houston TX 77072
Founded
2013

Similar labs. Evotec, Hope Medicine (HopeMed), Biofidus GmbH, Esco Aster

Found in a contract services directory. Listing built from allterum.com. Work here? Claim this listing.

Allterum Therapeutics · Midgard Science